Medigene AG. (2/1/23). "Press Release: Medigene AG Appoints Pamela Keck as Vice President of Investor Relations and Corporate Communications". Planegg. |
2023-02-01 |
Ariceum Therapeutics GmbH. (2/1/23). "Press Release: Ariceum Therapeutics Appoints Radioligand Expert, Germo Gericke, M.D., as Chief Medical Officer". Berlin. |
2023-02-01 |
va-Q-tec AG. (1/30/23). "Press Release: Management and Supervisory Boards of va-Q-tec AG Recommend Acceptance of EQT Private Equity’s Voluntary Public Takeover Offer". Würzburg. |
2023-01-30 |
Endress+Hauser AG. (1/27/23). "Press Release: Change at the Top of Analytik Jena. Ulrich Krauss Charts New Course; Oliver Klaeffling Set to Become Managing Director". |
2023-01-27 |
Epigenomics AG. (1/27/23). "Press Release: Resignation of Supervisory Board Chairman Heino von Prondzynski". Berlin. |
2023-01-27 |
Evotec SE. (1/26/23). "Press Release: Evotec Announces Agreement with Janssen to Develop Immune-based Therapies". Hamburg. |
2023-01-26 |
High-Tech Gründerfonds Management GmbH. (1/26/23). "Press Release: Refined Laser Systems Raises €2.7m to Diagnose Cancer in Minutes". Münster. |
2023-01-26 |
Rewind Therapeutics. (1/25/23). "Press Release: Rewind Therapeutics Raises Additional Funding and Adds Sunstone Life Science Ventures A/S as New Investor". Leuven. |
2023-01-25 |
Indivumed GmbH. (1/25/23). "Press Release: Crown Bioscience to Acquire Indivumed’s Service Business and Supporting Biobank". San Diego, CA & Hamburg. |
2023-01-25 |
Co.don GmbH. (1/25/23). "Press Release: Co.don Finally Saved – Investor Has Taken Over the Business Operations of the Leipzig-based Biopharmacy Vompany with an Additional Location in Teltow, Brandenburg". Leipzig & Teltow. |
2023-01-25 |
Memo Therapeutics AG. (1/24/23). "Press Release: Memo Therapeutics AG Announces Positive Phase I Data with AntiBKV for Treatment of BKV Infection in Renal Transplant Patients". Schlieren. |
2023-01-24 |
Novartis AG. (1/24/23). "Press Release: Sandoz Announces Agreement to Acquire Leading Antifungal Agent Mycamine from Astellas, Reinforcing Hospital Offering and Leading Anti-infectives Portfolio". Basel. |
2023-01-24 |
Boehringer Ingelheim. (1/24/23). "Press Release: US FDA Accepts Supplemental New Drug Application for Jardiance for Adults with Chronic Kidney Disease". Ingelheim & Indianapolis, IN. |
2023-01-24 |
Qiagen N.V.. (1/23/23). "Press Release: Qiagen Digital Insights Launches Ultra-fast NGS Analysis Able to Process a Whole Genome in 25 Minutes for a $1 in Cloud Computing Costs". Redwood City, CA & Hilden. |
2023-01-23 |
TME Pharma N.V.. (1/23/23). "Press Release: TME Pharma Provides Clinical Update on the GLORIA Expansion Arm Testing NOX-A12 in Combination with Radiotherapy and Bevacizumab in Patients with Glioblastoma". Berlin. |
2023-01-23 |
Bayer AG. (1/19/23). "Press Release: Bayer Launches New Collaboration with Oerth Bio to Further Advance Innovations in Crop Protection". Monheim & Durham NC. |
2023-01-19 |
InSphero AG. (1/19/23). "Press Release: Brenus Pharma and InSphero Receive €1.5 Million in Grants from the European EUROSTARS Fund". Lyon & Schlieren. |
2023-01-19 |
Biosynth AG. (1/19/23). "Press Release: Biosynth Hit 1M Products in Catalog. The Widest Catalog to Be the Leading Global Supplier". |
2023-01-19 |
ASG Superconductors S.p.A.. (1/18/23). "Press Release: ASG Superconductors and Siemens Healthineers Join Forces to Deliver 10.5T Ultra High Field MRI Systems for Ground-breaking Brain Research". Genoa. |
2023-01-18 |
Plasmion GmbH. (1/18/23). "Press Release: Plasmion and Agilent Technologies Announce Co-marketing Agreement to Provide Solutions for Life Sciences and Applied Chemical Markets". Augsburg. |
2023-01-18 |
Bayer AG. (1/18/23). "Press Release: Bayer Acquires Blackford Analysis Ltd. Bolstering the company’s Position in Digital Medical Imaging [not intended for U.S. and UK Media]". Berlin. |
2023-01-18 |
Medigene AG. (1/18/23). "Press Release: Medigene Receives $3 Million Milestone Payment from 2seventy bio". Planegg. |
2023-01-18 |
BioGeneration Ventures B.V.. (1/17/23). "Press Release: BGV Appoints Jaap de Bruin as FIRST Fund Investment Manager and Promotes Rianne Ellenbroek to Principal". Amsterdam. |
2023-01-17 |
Optibrium Ltd.. (1/17/23). "Press Release: Optibrium Appoints Steve Yemm as Chief Commercial Officer". Cambridge. |
2023-01-17 |
Qiagen N.V.. (1/17/23). "Press Release: Qiagen Launches EZ2 Connect MDx Platform for Automated Sample Processing in". Venlo. |
2023-01-17 |
Pureos Partners AG. (1/17/23). "Press Release: Pureos Partners Welcomes Dr. Ulf Grawunder to Its Team as Venture Partner". Pfäffikon. |
2023-01-17 |
Ruhr-Universität-Bochum. (1/17/23). "Pressemitteilung: Alzheimer-Frühdiagnostik – Spin-Off BetaSense zieht ins BioMedizinZentrum". |
2023-01-17 |
ImmunOs Therapeutics AG. (1/17/23). "Press Release: ImmunOs Therapeutics Receives Regulatory Approval for First-In-Human Trial of IOS-1002". Schlieren. |
2023-01-17 |
Ensilicated Technologies Ltd. (EnsiliTech). (1/17/23). "Press Release: Ensilicated Technologies Raises £1.2m to Develop Technology that Eliminates Need for Vaccine Refrigeration". Bristol. |
2023-01-17 |
TetraScience, Inc.. (1/12/23). "Press Release: Labforward Joins the Tetra Partner Network to Eliminate Data Silos and Error-Prone Data Transfers". Boston, MA. |
2023-01-12 |
Bayer AG. (1/11/23). "Press Release: Bayer to Accelerate Drug Discovery with Google Cloud’s High-Performance Compute Power". Berlin & Sunnyvale, CA. |
2023-01-11 |
BioNTech SE. (1/10/23). "Press Release: BioNTech to Acquire InstaDeep to Strengthen Pioneering Position in the Field of AI-powered Drug Discovery, Design and Development". Mainz & London. |
2023-01-10 |
CureVac N.V.. (1/10/23). "Press Release: CureVac Appoints Alexander Zehnder as CEO from April 1, 2023". Mainz & London. |
2023-01-10 |
Bayer AG. (1/10/23). "Press Release: NextPoint Therapeutics Announces $80 Million Series B Financing Co-led by Leaps by Bayer and Sanofi Ventures to Advance Novel Immuno-Oncology Programs". Cambridge, MA & Leverkusen. |
2023-01-10 |
ProBioGen AG. (1/10/23). "Press Release: ProBioGen Collaborates with Boehringer Ingelheim on DirectedLuck Transposase Technology". Berlin. |
2023-01-10 |
Sernova Corporation. (1/10/23). "Press Release: Sernova and Evotec on Track to Initiate Clinical Testing of the First iPSC-Derived Islets in Cell Pouch as a Potential Functional Cure for Type 1 Diabetes". London, ON. |
2023-01-10 |
Medios AG. (1/10/23). "Press Release: Medios AG. Successful Completion of the Acquisition of bbw – Significant Expansion of Compounding Volume". Berlin. |
2023-01-10 |
Idorsia Ltd.. (1/9/23). "Press Release: Idorsia Presents at the 41st J.P. Morgan Healthcare Conference – Achievements in 2022 Provide the Foundation for Our Success in 2023". Allschwil. |
2023-01-09 |
Proteros Biostructures GmbH. (1/9/23). "Press Release: Proteros Receives Minority Investment from Private Equity Firm Inflexion". Martinsried. |
2023-01-09 |
Boehringer Ingelheim. (1/9/23). "Press Release: Boehringer Ingelheim and 3T Biosciences Join Forces to Develop Next-Generation Cancer Immunotherapies". Ingelheim & South San Francisco, CA. |
2023-01-09 |
Qiagen N.V.. (1/9/23). "Press Release: Qiagen Completes Acquisition of Verogen, Strengthening Leadership in Human ID / Forensics with NGS Technologies". Venlo & San Diego, CA. |
2023-01-09 |
Alentis Therapeutics AG. (1/9/23). "Press Release: Positive Results from Single Ascending Dose Phase 1 Study of ALE.F02 Targeting Claudin-1". Basel. |
2023-01-09 |
BioNTech SE. (1/6/23). "Press Release: BioNTech Announces Strategic Partnership with UK Government to Provide up to 10,000 Patients with Personalized mRNA Cancer Immunotherapies by 2030". Mainz. |
2023-01-06 |
CureVac N.V.. (1/6/23). "Press Release: CureVac Announces Positive Data on Joint COVID-19 and Flu mRNA Vaccine Development Programs". Tübingen & Boston, MA. |
2023-01-06 |
BioVersys AG. (1/5/23). "Press Release: BioVersys Extends Its Series C Round to CHF 32.6 Million with investment from the AMR Action Fund". Basel. |
2023-01-05 |
Bruker Corporation. (1/5/23). "Press Release: Bruker Announces Acquisition of Acquifer Imaging GmbH". Heidelberg. |
2023-01-05 |
PhoreMost Ltd.. (1/5/23). "Press Release: PhoreMost Reaches Milestone in a Target Discovery Alliance with Boehringer Ingelheim". Cambridge. |
2023-01-05 |
Nimble Therapeutics. (1/5/23). "Press Release: Nimble Therapeutics Announces Expansion of its Discovery and Development Partnership with Genentech". Madison, WI. |
2023-01-05 |
ADC Therapeutics S.A.. (1/4/23). "Press Release: ADC Therapeutics to Participate in the 41st Annual J.P. Morgan Healthcare Conference". Lausanne. |
2023-01-04 |
Bruker Corporation. (1/4/23). "Press Release: Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker Customers". Lausanne. |
2023-01-04 |
Hookipa Pharma Inc.. (1/4/23). "Press Release: Hookipa Pharma Achieves $5 Million Milestone Payment from Gilead Sciences for Progress in the Development of Hepatitis B Vaccine". New York, NY & Vienna. |
2023-01-04 |
Ethris GmbH. (12/29/22). "Press Release: Cipla EU to Invest EUR 15 million in Ethris, Initiating a Strategic Collaboration". Mumbai & Munich. |
2022-12-29 |
BioNTech SE. (12/28/22). "Press Release: BioNTech to Present at the 41st Annual J.P. Morgan Healthcare Conference". Mainz. |
2022-12-28 |
BioNTech SE. (12/23/22). "Press Release: BioNTech Initiates Phase 1 Clinical Trial for Malaria Vaccine Program BNT165". Mainz. |
2022-12-23 |
aws Gründerfonds. (12/23/22). "Pressemitteilung: aws Gründerfonds investiert in nachhaltiges Lebensmittel-Startup Arkeon". Tulln & Wien. |
2022-12-23 |
Ryvu Therapeutics S.A.. (12/22/22). "Press Release: Ryvu Therapeutics Announces Closing of Equity Offering with Gross Proceeds over PLN 250 Million". Krakow. |
2022-12-22 |
Merck KGaA. (12/22/22). "Press Release: Merck Announces Collaboration with Mersana Therapeutics to Develop Novel Immunostimulatory Antibody-Drug Conjugates". Darmstadt. |
2022-12-22 |
MDG Molecular Diagnostics Group GmbH. (12/21/22). "Press Release: Molecular Diagnostics Group and Swiss 4D Lifetec AG Become Strategic Partners". |
2022-12-21 |
ADC Therapeutics S.A.. (12/21/22). "Press Release: ADC Therapeutics and Sobi Announce European Commission Approval of Zynlonta (loncastuximab tesirine) for the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma". Lausanne. |
2022-12-21 |
Bruker Corporation. (12/21/22). "Press Release: Bruker Corporation to Present at the 41st Annual J.P. Morgan Healthcare Conference". Billerica, MA. |
2022-12-21 |
InflaRx N.V.. (12/21/22). "Press Release: InflaRx Announces Amendment of Co-Development Agreement and Additional Equity Investment by Staidson in Connection with Regulatory Filing in China for Anti-C5a-Antibody for Treatment of COVID-19". Jena. |
2022-12-21 |
Ethris GmbH. (12/21/22). "Press Release: Ethris Announces Collaboration with DIOSynVax and CEPI to Develop a Broadly Protective mRNA Vaccine Against Betacoronaviruses". Munich. |
2022-12-21 |
BioNTech SE. (12/21/22). "Press Release: BioNTech Starts Phase 1 Clinical Trial for Prophylactic Herpes Simplex Virus-2 Vaccine Candidate BNT163". Mainz. |
2022-12-21 |
BioNTech SE. (12/21/22). "Press Release: Update on First BioNTainer for African-based mRNA Manufacturing Facility". Mainz. |
2022-12-21 |
European Invesmtent Bank (EIB). (12/20/22). "Press Release: Germany – EIB Provides €20 Million in Financing to Innovative Diagnostics Developer Numares". |
2022-12-20 |
MorphoSys AG. (12/20/22). "Press Release: Chief Financial Officer Sung Lee to Leave MorphoSys in March 2023". Planegg. |
2022-12-20 |
Boehringer Ingelheim. (12/20/22). "Press Release: Boehringer Ingelheim Announces Appointments to Board of Managing Directors". Ingelheim. |
2022-12-20 |
CN Bio Innovations Ltd.. (12/19/22). "Press Release: CN Bio Appoints Dr Paul Brooks as Chief Executive Officer". Cambridge. |
2022-12-19 |
Eckert & Ziegler Strahlen- und Medizintechnik AG. (12/19/22). "Press Release: Changes in the Management Board of Eckert & Ziegler. Insider Information Pursuant to Article 17 MAR". Cambridge. |
2022-12-19 |
ADC Therapeutics S.A.. (12/19/22). "Press Release: ADC Therapeutics Appoints Jose Carmona as Chief Financial Officer". Lausanne. |
2022-12-19 |
Nykode Therapeutics A/S. (12/19/22). "Press Release: Nykode Therapeutics and Richter-Helm BioLogics Announce Strategic Manufacturing Partnership". Oslo. |
2022-12-19 |
CRISPR Therapeutics AG. (12/19/22). "Press Release: CRISPR Therapeutics Announces the Appointment of Alex Harding, M.D., M.B.A., as Head of Business Development". Zug & Boston, MA. |
2022-12-19 |
Boehringer Ingelheim. (12/19/22). "Press Release: Boehringer Ingelheim and Click Therapeutics Expand Their Existing Collaboration to Develop Prescription Digital Therapeutics for Schizophrenia". Ingelheim & New York, NY. |
2022-12-19 |
Polyplus-transfection S.A.. (12/17/22). "Press Release: Polyplus Acquires Xpress Biologics to Expand Plasmid DNA Offer". Strasbourg. |
2022-12-17 |
BioSpring GmbH. (12/16/22). "Press Release: BioSpring Expands in Offenbach – up to 1,500 New Jobs". Offenbach am Main. |
2022-12-16 |
Beiersdorf AG. (12/16/22). "Press Release: Beiersdorf Acquires S-Biomedic and Strengthens Expertise in the Field of Acne Treatment". Hamburg. |
2022-12-16 |
T-Curx GmbH. (12/15/22). "Press Release: T-Curx GmbH Announces the Appointment of Thomas (Tom) Loeser as CFO and the Attendance at the JPM 41st Annual Healthcare Conference 2023 in San Francisco". Würzburg. |
2022-12-15 |
Minervax ApS. (12/15/22). "Press Release: Minervax Announces 72M EUR Financing to Advance Development of Novel Vaccine against Group B Streptococcus". Copenhagen. |
2022-12-15 |
Storm Therapeutics Ltd.. (12/14/22). "Press Release: Storm Therapeutics Announces Closing of USD $30M Series B Financing". Cambridge. |
2022-12-14 |
Lipotype GmbH. (12/13/22). "Press Release: Lipotype, a Leading Lipidomics Service Provider, Launches US Subsidiary in Cambridge, Massachusetts". Cambridge, MA & Dresden. |
2022-12-13 |
Amgen Inc.. (12/13/22). "Press Release: Blincyto (blinatumomab) Added to Consolidation Chemotherapy Significantly Improves Survival in Adult Patients with Measurable Residual Disease-negative B-Lieage Acute Lymphoblastic Leukemia (B-ALL)". Thousand Oaks, |
2022-12-13 |
Merck KGaA. (12/13/22). "Press Release: Merck Signs MoU with Synplogen to Accelerate Development and Manufacturing of Viral Vector-based Gene Therapy Applications". Tokyo. |
2022-12-13 |
BioM Biotech Cluster Development GmbH. (12/12/22). "Press Release: Martinsried Gets Start-up Incubator Munich Accelerator Life Sciences & Medicine (MAxL)". Martinsried. |
2022-12-12 |
TGZ Halle Technologie- und Gründerzentrum Halle GmbH. (12/12/22). "Pressemitteilung: Minister Schulze übergibt Fördermittelbescheide für Neubauten". |
2022-12-12 |
Genedata AG. (12/12/22). "Press Release: Icosagen Chooses Genedata Biologics to Digitalize Recombinant Antibody Discovery". Basel. |
2022-12-12 |
Stadt Köln. (12/9/22). "Pressemitteilung: Rat gibt Mittel für Planung von Neubauten auf dem BioCampus Cologne frei". |
2022-12-09 |
Sartorius AG. (12/8/22). "Press Release: Sartorius Agrees with Bico on Strategic Cooperation as well as a 10 Percent Capital Investment". Göttingen. |
2022-12-08 |
Max Planck Institute of Biochemsitry. (12/8/22). "Press Release: Karsten Borgwardt Becomes Director at the Max Planck Institute of Biochemistry". Martinsried. |
2022-12-08 |
Ryvu Therapeutics S.A.. (12/8/22). "Press Release: Ryvu Therapeutics Initiates Public Offering of Shares [not for US, AU, CA, et al.]". Krakow. |
2022-12-08 |
High-Tech Gründerfonds Management GmbH. (12/7/22). "Press Release: Variolytics Receives Seven-figure Seed Funding for Climate-neutral Wastewater Treatment Plants". Stuttgart. |
2022-12-07 |
Merck KGaA. (12/6/22). "Press Release: Merck Gains Leading Perfusion Micro-Bioreactor with Erbi Biosystems Acquisition". Darmstadt. |
2022-12-06 |
MorphoSys AG. (12/6/22). "Press Release: MorphoSys Out Licenses Pre-Clinical Oncology Program". Planegg. |
2022-12-06 |
Bruker Corporation. (12/5/22). "Press Release: Bruker Completes the Acquisition of Neurescence Inc.". Billerica, MA. |
2022-12-05 |
Fresenius Medical Care AG & Co. KGaA. (12/5/22). "Press Release: Helen Giza to Take Over as Chief Executive Officer of Fresenius Medical Care". |
2022-12-05 |
faCelliate GmbH. (11/30/22). "Press Release: faCellitate Appoints Christoph Petry, Ph.D. to Become Managing Director and CEO". Mannheim. |
2022-11-30 |
BioNTech SE. (11/30/22). "Press Release: BioNTech and Ryvu Therapeutics Enter into Global Collaboration to Develop and Commercialize Immuno-Modulatory Small Molecule Candidates". Mainz & Krakow. |
2022-11-30 |
MiGenTra GmbH. (11/29/22). "Press Release: Bioventure, Minapharm Pharmaceuticals and MiGenTra Sign an Exclusive Agreement for the Commercialization of Multiple Biosimilar Candidates of Alvotech in the Middle East and Africa". |
2022-11-29 |
Cajal Neuroscience. (11/29/22). "Press Release: Cajal Neuroscience Launches with $96 Million to Transform Target and Drug Discovery in Neurodegeneration". Seattle, WA. |
2022-11-29 |
Rgenta Therapeutics, Inc.. (11/29/22). "Press Release: Rgenta Therapeutics Raises $52M in Series A Financing". Cambridge, MA. |
2022-11-29 |
Technische Universität München. (11/28/22). "Press Release: Nanoswitches for Tumor Targeting. TUM Spin-off Plectonic Develops Antibody-based Immunotherapies". |
2022-11-28 |